HSCSW

Value Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 4 3501 9002 4190 8 669 Gross profit 2 4701 1401 4110 5 021 Operating expenses 1.92 M1.88 M2.07 M1.93 M 7.8 M Selling/general/admin expenses 993.78 K878.05 K1.35 M1.29 M 4.51 M Research & development 929.09 K997.21 K727.03 K638.58 K 3.29 M Operating income -1.92 M-1.87 M-2.07 M-1.93 M -7.8 M Non-Operating Income, Total -173.93 K-180.88 K-277.37 K-56.27 K -688.44 K Interest expense, net of interest capitalized 180.85 K183.69 K279.53 K61.51 K 705.58 K Non-Operating Income, excl. Interest Expenses -361.7 K-367.38 K-559.07 K-123.02 K -1.41 M Unusual income/expense 6 9212 8132 1685 241 17.14 K Pretax income -2.28 M-2.24 M-2.63 M-2.05 M -9.19 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -2.09 M-2.05 M-2.35 M-1.99 M -8.49 M Discontinued operations ———— — Net income -2.09 M-2.05 M-2.35 M-1.99 M -8.49 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -2.09 M-2.05 M-2.35 M-1.99 M -8.49 M Basic earnings per share (Basic EPS) -1.86-1.58-0.85-0.63 -4.92 Diluted earnings per share (Diluted EPS) -1.86-1.58-0.85-0.63 -4.92 Average basic shares outstanding 938.26 K1.3 M2.78 M3.16 M — Diluted shares outstanding 938.26 K1.3 M2.78 M3.16 M — EBITDA -1.8 M-1.76 M-1.8 M-1.9 M -7.26 M EBIT -1.92 M-1.87 M-2.07 M-1.93 M -7.8 M Cost of revenue 1 8807601 0080 3 648 Other cost of goods sold ———— — Depreciation & amortization (cash flow) 117.46 K117.06 K270.89 K28.2 K 533.61 K